Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.
Li X, Ma X, Miao Y, Zhang J, Xi B, Li W, Zhang Q, Chen L, Yang Y, Li H, Wei L, Zhou H, Yang C.
Li X, et al. Among authors: li w, li h.
J Cell Mol Med. 2023 Feb;27(3):422-434. doi: 10.1111/jcmm.17665. Epub 2023 Jan 18.
J Cell Mol Med. 2023.
PMID: 36651446
Free PMC article.